Furthermore, colorectal cancer is a highly heterogeneous clinical entity; genetic KRAS, NRAS, BRAF, or HER2 genes also work as the critical diagnostic and prognostic biomarkers. This evidence concerns the gene BRAF and colorectal cancer.